Delivery Order SPE2DH25D0001-SPE2D425F635D
- Not listed
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $2,589.00 by the Defense Department's Medical Supply Chain office on August 11, 2025, with an ultimate completion date of August 13, 2025. The contract, which does not utilize a set-aside designation, calls for the delivery of CHEM 8 cartridges to the North Chicago, Illinois location. The fixed-price contract with economic price adjustment provisions represents a task order against an...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order on September 4, 2025, for CHEM 8 CARTRIDGE supplies, with a ceiling value of $1,799.25. This fixed-price contract with economic price adjustment authority will be performed in North Chicago, Illinois, and is scheduled for completion by September 8, 2025. The contract was awarded without set-aside designation, indicating full and open competition. The funding source is the Defense Medical Supply...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order on August 28, 2025, for CHEM 8 cartridges with a ceiling value of $1,832.50. This fixed-price contract with economic price adjustment will be performed in North Chicago, Illinois, and is scheduled for completion by September 2, 2025. The award was made without a set-aside designation, indicating full and open competition. The funding agency is the Medical Supply Chain within the Department of...
- The U.S. Defense Medical Supply Chain awarded a $2,199.00 fixed-price delivery order with economic price adjustment to Abbott Laboratories Inc. (Abbott Point of Care division) on August 25, 2025, for the supply of Chemistry 8 cartridges. The contract, which reaches ultimate completion on August 27, 2025, was awarded without set-aside designation, indicating full and open competition. Performance will occur at Abbott's North Chicago, Illinois facility, where the company manufactures point-of-care...
- Abbott Laboratories Inc., through its Abbott Point of Care division, received a delivery order award on August 28, 2025, for CHEM 8 CARTRIDGE supplies with a ceiling value of $5,864.00. This fixed-price contract with economic price adjustment will be performed in North Chicago, Illinois, and is scheduled for completion by September 2, 2025. The award was issued without a set-aside designation, indicating full and open competition. The funding source is the Defense Medical Supply Chain,...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order on September 2, 2025, for CHEM 8 Cartridge supplies with a ceiling value of $11,728.00. This fixed-price contract with economic price adjustment will be performed in North Chicago, Illinois, with an ultimate completion date of September 4, 2025. The award was made without a set-aside designation, indicating full and open competition. The contract is funded by the Defense Medical Supply Chain,...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order on August 14, 2025, for CHEM 8 Cartridge supplies with a ceiling value of $3,395.00. The contract is a fixed price agreement with economic price adjustment provisions and carries an ultimate completion date of August 18, 2025. The work will be performed in North Chicago, Illinois, and no set-aside designation was used in this award, indicating full and open competition. The funding agency is the...
- Abbott Laboratories Inc., a global healthcare company headquartered in North Chicago, Illinois, received a delivery order award on August 8, 2025, for CHEM 8 Cartridge supplies with a ceiling value of $1,136.00. This fixed-price contract with economic price adjustment was awarded by the Medical Supply Chain organization within the Department of Defense with no set-aside designation, indicating full and open competition. The place of performance is North Chicago, Illinois, where Abbott...
- Abbott Laboratories Inc., through its Abbott Point of Care division, received a delivery order award on August 13, 2025, for CHEM 8 Cartridge supplies with a ceiling value of $1,199.50. This fixed-price contract with economic price adjustment has an ultimate completion date of August 15, 2025, and will be performed in North Chicago, Illinois. The contract was awarded by the Defense-focused Medical Supply Chain federal agency without a set-aside designation, indicating full and open...
- Abbott Laboratories Inc. was awarded a delivery order valued at $2,252.57 for CHEM 8 Cartridge supplies on July 21, 2025, with an ultimate completion date of July 23, 2025. This fixed-price delivery order with economic price adjustment was issued by the Defense Medical Supply Chain and will be performed in North Chicago, Illinois. The contract was awarded without a set-aside designation, indicating full and open competition. As a child contract action, this delivery order likely derives from a...
- SPE2DH25D0001Indefinite Delivery Contract
- SPE2DH25D0001-SPE2D425F635DDelivery Order
Abbott Laboratories Inc., through its Abbott Point of Care division, received a fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on September 7, 2025, for CHEM 8 cartridges with a ceiling value of $2,272.00. The delivery order, which is not subject to any set-aside designation, indicates full and open competition and requires completion by September 9, 2025. The point-of-performance location is North Chicago, Illinois, where Abbott maintains significant manufacturing and distribution operations. This delivery order is issued under Abbott's existing Blanket Purchase Agreement vehicles, which enable the Department of Defense and its affiliates to efficiently procure critical diagnostic and laboratory products through streamlined procurement mechanisms. CHEM 8 cartridges are chemistry analyzer reagents essential for clinical laboratory testing, supporting military medical facilities and defense healthcare operations. The contract reflects Abbott's established role as a key supplier of in-vitro diagnostic products and point-of-care testing technologies to federal healthcare systems, consistent with the company's broader portfolio of defense medical supply contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/7/25 |